Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
The Journal of Pathology|May 31, 2020
Gremlin 1 - small protein, big impact: the multiorgan consequences of disrupted BMP antagonism<sup>†</sup>Sarah Gooding, Simon J LeedhamFrontiers in Oncology|November 28, 2022
Tumor and microenvironmental mechanisms of resistance to immunomodulatory drugs in multiple myelomaLucia Y Chen, Sarah GoodingCurrent Opinion in Pharmacology|March 29, 2016
New approaches to targeting the bone marrow microenvironment in multiple myelomaSarah Gooding, Claire M EdwardsMaturitas|December 27, 2014
Managing multiple myeloma in the over 70s: a reviewAndrew J King, Sarah Gooding, Karthik RamasamyHaematologica|November 21, 2024
Resistance to immunomodulatory drugs in multiple myeloma: the cereblon pathway and beyondPhaik Ju Teoh, Mun Yee Koh, Constantine Mitsiades, et al.International Journal of Hematology|March 4, 2014
Gemcitabine-induced large vessel vasculitis demonstrated by PET CT: a rare, important side effectToby A Eyre, Sarah Gooding, Ishita Patel, et al.BMJ Open|April 6, 2022
Precision medicine for liver tumours with quantitative MRI and whole genome sequencing (Precision1 trial): study protocol for observational cohort studyFenella K Welsh, John J Connell, Matt Kelly, et al.The Cochrane Database of Systematic Reviews|August 22, 2013
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemiaSheila A Fisher, Susan J Brunskill, Carolyn Doree, et al.The Cochrane Database of Systematic Reviews|August 23, 2013
Oral deferiprone for iron chelation in people with thalassaemiaSheila A Fisher, Susan J Brunskill, Carolyn Doree, et al.The Journal of Infectious Diseases|October 21, 2010
Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated tuberculosisKerry A Millington, Sarah Gooding, Timothy S C Hinks, et al.Pageof 4